Insys, the Opioid Drug Maker, to Pay $225 Million to Settle Fraud Charges
The opioid manufacturer Insys Therapeutics agreed to pay $225 million to settle federal criminal and civil charges that it illegally marketed a highly addictive fentanyl painkiller to doctors, federal prosecutors said on Wednesday. As part of the deal, a subsidiary of Insys will plead guilty to five counts of mail fraud and the company will…
Details